Multinational pharmaceutical companies to benefit from new China guidelines: analysts

China's State Council has introduced new guidelines for innovative drug pricing, which analysts describe as the most significant in a decade. The guidelines aim to support patented drugs through value-based pricing while promoting competition to lower prices for generic drugs.